V P Nikitin Selected Research

Amnesia (Dissociative Amnesia)

1/2021	Protein synthesis inhibitor administration before a reminder caused recovery from amnesia induced by memory reconsolidation impairment with NMDA glutamate receptor antagonist.
1/2021	Learning against the Background of DNA Methyltransferase Inhibition Leads to the Formation of Memory That Is Resistant to Reactivation and Impairment.
6/2020	Peculiarities in Synthesis of Proteins Implicated in Memory Reconsolidation and Induction of Amnesia.
1/2020	Long-term memory consolidation or reconsolidation impairment induces amnesia with key characteristics that are similar to key learning characteristics.
10/2019	Changes in Amnesia Parameters over Time after Long-Term Memory Disruption with Protein Kinase Mζ Inhibitor.
5/2019	Administration of Protein Synthesis Inhibitor before Reminder Reverses Amnesia Induced by Memory Reconsolidation Impairment with 5-HT Receptors Antagonist.
1/2019	Protein synthesis inhibitors induce both memory impairment and its recovery.
11/2018	Peculiarities of Participation of DNA Methyltransferases in the Mechanisms of Storage, Impairment, and Recovery of Conditioned Food Aversion Memory.
1/2018	NMDA or 5-HT receptor antagonists impair memory reconsolidation and induce various types of amnesia.
11/2017	Anterograde Amnesia Induced by Disruption of Consolidation or Reconsolidation of Long-Term Memory.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

V P Nikitin Research Topics

Disease

30	Amnesia (Dissociative Amnesia) 01/2021 - 09/2006
2	Anterograde Amnesia 03/2022 - 12/2020
1	Memory Disorders (Memory Loss) 01/2021

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2021 - 09/2006
13	N-Methylaspartate (NMDA)IBA 01/2021 - 03/2010
12	Protein Synthesis InhibitorsIBA 01/2021 - 11/2007
11	Excitatory Amino Acid AntagonistsIBA 01/2021 - 03/2010
7	Cycloheximide (Cicloheximide)IBA 06/2020 - 03/2010
6	Glutamate Receptors (Glutamate Receptor)IBA 12/2020 - 12/2010
6	Dizocilpine Maleate (Dizocilpine)IBA 03/2016 - 10/2007
5	Neurotransmitter Receptors (Neurotransmitter Receptor)IBA 03/2022 - 09/2012
4	MethyltransferasesIBA 01/2020 - 02/2014
4	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 02/2014
4	Serotonin AntagonistsIBA 01/2018 - 12/2010
3	Glutamic Acid (Glutamate)FDA Link 01/2021 - 12/2010
3	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2021 - 12/2010
3	Serotonin ReceptorsIBA 05/2019 - 12/2010
3	MethiothepinIBA 01/2018 - 09/2008
3	alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA 11/2015 - 12/2010
2	AnisomycinIBA 01/2019 - 03/2010
2	Serotonin (5 Hydroxytryptamine)IBA 01/2018 - 03/2016
2	Cycloserine (Seromycin)FDA Link 09/2012 - 12/2010
1	RG108IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2020
1	PlasticsIBA 01/2020
1	Biological ProductsIBA 01/2020
1	Protein Kinases (Protein Kinase)IBA 10/2019
1	4- benzyl- 2- methyl- 1,2,4- thiadiazolidine- 3,5- dioneIBA 02/2017
1	AMPA Receptors (AMPA Receptor)IBA 05/2013
1	Messenger RNA (mRNA)IBA 09/2012
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 12/2010

Therapy/Procedure

13	Injections 01/2021 - 09/2012
1	Aftercare (After-Treatment) 09/2008